Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IGC Pharma (IGC) Equity Ratio (2016 - 2025)

IGC Pharma has reported Equity Ratio over the past 15 years, most recently at 0.83 for Q3 2025.

  • Quarterly Equity Ratio rose 16.74% to 0.83 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 0.83 through Sep 2025, up 16.74% year-over-year, with the annual reading at 0.72 for FY2025, 2.12% down from the prior year.
  • Equity Ratio was 0.83 for Q3 2025 at IGC Pharma, up from 0.77 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.94 in Q4 2021 and troughed at 0.69 in Q4 2024.
  • The 5-year median for Equity Ratio is 0.85 (2023), against an average of 0.84.
  • Year-over-year, Equity Ratio decreased 16.7% in 2024 and then increased 16.74% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.94 in 2021, then dropped by 3.12% to 0.91 in 2022, then dropped by 11.9% to 0.8 in 2023, then fell by 14.25% to 0.69 in 2024, then grew by 20.46% to 0.83 in 2025.
  • Per Business Quant, the three most recent readings for IGC's Equity Ratio are 0.83 (Q3 2025), 0.77 (Q2 2025), and 0.72 (Q1 2025).